Physician profile
Gary Michael Lepow
NPI 1114905510
$1,003,209.49
in general payments reported to CMS, 2019-2025
36 companies · $8,221 in 2025
The $8,221 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $15K · 2021: $17K · 2022: $804K · 2023: $100K · 2024: $30K · 2025: $8,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $105K · Royalty Or License: $24K · Travel and Lodging: $3,574 · Consulting Fee: $2,750 · Grant: $1,000 · Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $105,253.75 |
| Royalty Or License | $24,445.82 |
| Travel and Lodging | $3,573.61 |
| Consulting Fee | $2,750.00 |
| Grant | $1,000.00 |
| Food and Beverage | $915.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $917,706.93 | 2022-2025 | Avenger Radial Head, +4 Stems, Allograft Tissue, Alloaid |
| In2bones USA, LLC | $62,114.65 | 2019-2022 | |
| Stryker Corporation | $7,855.32 | 2019-2024 | Augment Injectable |
| Wright Medical Technology, INC. | $5,513.49 | 2019-2020 | |
| Medinc of Texas | $3,843.93 | 2019-2020 | |
| Heron Therapeutics, INC. | $1,182.26 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $911.59 | 2020-2023 | |
| Arthrex, INC. | $830.00 | 2019 | |
| Trimed, INC. | $582.02 | 2019-2021 | |
| Kerecis Limited | $415.98 | 2019 | |
| Medline Industries Lp | $266.17 | 2019 | |
| Paratek Pharmaceuticals, INC. | $158.67 | 2023-2024 | Nuzyra |
| Boston Scientific Corporation | $140.99 | 2023 | |
| Abbott Laboratories | $139.86 | 2023 | Proclaim |
| Smith+Nephew, INC. | $136.26 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $133.08 | 2023-2025 | |
| Paragon 28, INC. | $122.95 | 2019-2023 | Activcore Nail |
| Organogenesis INC. | $113.90 | 2022 | |
| Misonix INC | $100.33 | 2019 | |
| Grt US Holding, INC. | $97.58 | 2022 | |
| Abbvie INC. | $95.65 | 2021 | |
| Janssen Scientific Affairs, LLC | $92.99 | 2022 | |
| Melinta Therapeutics, LLC | $73.13 | 2021 | |
| Amgen INC. | $71.38 | 2025 | Krystexxa |
| Crossroads Extremity Systems, LLC | $70.53 | 2021 | |
| Bard Peripheral Vascular, INC. | $62.36 | 2019 | |
| Tei Medical INC. | $58.29 | 2019 | |
| Biotissue Holdings INC. | $57.55 | 2025 | |
| Integra Lifesciences Corporation | $54.66 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Axogen | $44.05 | 2019 | |
| Baxter Healthcare | $31.63 | 2019 | |
| Ermi LLC | $25.85 | 2019 | |
| Averitas Pharma INC. | $24.79 | 2023 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $16.21 | 2023 | Seglentis |
| Zimmer Biomet Holdings, INC. | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$36,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Lepow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.